Lu Siqi S - OmicsDI

Show results for

Proteomics (2)
Metabolomics (2)

Organisms

Mus musculus (2)

Repository

iProX (2)
MetaboLights (2)

Technology Type

Mass spectrometry (2)

Instrument Platform

Xevo G2 QTOF (Waters) (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2024 (1)
2023 (1)
2021 (1)
2017 (1)

CHEBI ID

CHEBI:167859 (1)
CHEBI:167856 (1)
CHEBI:167854 (1)
CHEBI:167851 (1)
CHEBI:167848 (1)
CHEBI:167847 (1)
CHEBI:167844 (1)
CHEBI:167843 (1)
CHEBI:167839 (1)
CHEBI:167834 (1)
CHEBI:167831 (1)
CHEBI:167829 (1)
CHEBI:167828 (1)
CHEBI:167813 (1)
CHEBI:167811 (1)
CHEBI:167805 (1)
CHEBI:167801 (1)
CHEBI:167799 (1)
CHEBI:167793 (1)
CHEBI:167791 (1)
CHEBI:167787 (1)
CHEBI:167778 (1)
CHEBI:167776 (1)
CHEBI:167773 (1)
CHEBI:167772 (1)
CHEBI:167769 (1)
CHEBI:167767 (1)
CHEBI:167764 (1)
CHEBI:167759 (1)
CHEBI:167757 (1)

Metabolite Name

3-acetyl-11-keto-beta-boswellic acid (1)
3-methyl-2-oxindole (1)
2-trans-hexadecenoic acid (1)
Rac-glycerol 1-myristate (1)
Methyl 2-hydroxy-4-{3-[(4-oxo-3-phenyl-4h-chromen-7-yl)oxy]propoxy}-3-propylbenzoate (1)
Palmitelaidic acid methyl ester (1)
5-hydroxy-3-(hydroxymethyl)-6-isopropyl-2-oxo-3-cyclohexen-1-yl 3-methylpentanoate (1)
N-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbothioamide (1)
7-hydroxytestosterone (1)
4-(methylthio) aniline (1)
Methyl 4-(aminocarbonyl)-n-cyanotetrahydropyridine-1(2H)-carbimidothioate (1)
Alpha-pinene-2-oxide (1)
Ethyl 3-[2-(diphenylmethylidene)hydrazino]but-2-enoate (1)
N-[3-(aminosulfonyl)phenyl]-2-phenoxynicotinamide (1)
5-dihydrotestosterone (1)
3-{4-[(4-fluorophenyl)sulfonyl]piperazino}-4H-chromen-4-one (1)
Delta9-THC (1)
3-(benzylamino)-5-(4-chlorophenyl)cyclohex-2-en-1-one (1)
L-aspartic acid beta-benzyl ester (1)
Beta-asarone (1)
11-hydroxy-17-methyltestosterone (1)
6-O-methylscutellarin (1)
DL-metanephrine (1)
4-methoxycinnamaldehyde (1)
6-hydroxycortisol (1)
N1-[2-({[3-chloro-5-(trifluoromethyl)-2-pyridyl]methyl}thio)ethyl]benzamide (1)
Ethyl 3-cyano-6-methyl-2-({2-[(2-thienylcarbonyl)amino]phenyl}thio)isonicotinate (1)
2-(propylthio)nicotinic acid (1)
N'-cyano-N-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carboximidamide (1)
N-oleoyl dopamine (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

The trans-omics landscape of COVID-19

The outbreak of coronavirus disease 2019 (COVID-19) is a global health emergency. Various omics results have been reported for COVID-19, but the molecular hallmarks of COVID-19, especially in those patients without comorbidities, have not been fully investigated. Here we collect blood samples from 2...

2021-10-06 | MTBLS2542 | MetaboLights

Lipidomic profiling reveals distinct differences in plasma lipid composition in healthy, prediabetic and type 2 diabetic individuals

The relationship between dyslipidemia and type 2 diabetes mellitus (T2D) has been extensively reported, but the global lipid profiles, especially in the East Asia population, associated with the development of T2D remain to be characterized. Liquid chromatography coupled to tandem mass spectromet...

2017-04-26 | MTBLS352 | MetaboLights

Hematopoietic stem and progenitor cell membrane-coated vesicles for bone marrow-targeted leukaemia drug delivery

To investigate the cellular and molecular mechanisms underlying the specific targeting of HSPC-Lipo nanoparticles to the bone marrow of leukemic mice, we performed mass spectrometry to map the proteomics of HSPC-Lipo nanoparticles and HSPC cell membrane.

ORGANISM(S): Mus Musculus

2024-06-06 | PXD052979 |

Peptide codes for organ-selective mRNA delivery

Organ-selective delivery of messenger RNA (mRNA) is critical for fulfilling the therapeutic potential of mRNA-based gene and protein replacement technologies. Despite clinical advances in hepatic delivery of mRNA using lipid nanoparticles (LNPs), strategies for extrahepatic organ-selective mRNA deli...